Pneumococcal conjugate vaccine schedule: 3+1, 2+1, or 1+1? - Suppr | 超能文献

Pneumococcal conjugate vaccine schedule: 3+1, 2+1, or 1+1?

作者信息

Levy Corinne, Cohen Robert

机构信息

Université Paris Est, IMRB-GRC GEMINI, 94000 Créteil, France; Association Clinique et Thérapeutique Infantile du Val de Marne (ACTIV), Créteil, France; Clinical Research Center, Centre Hospitalier Intercommunal de Créteil, Créteil, France; Groupe de Pathologie Infectieuse Pédiatrique, Paris, France; Association Française de Pédiatrie Ambulatoire (AFPA), France.

Université Paris Est, IMRB-GRC GEMINI, 94000 Créteil, France; Association Clinique et Thérapeutique Infantile du Val de Marne (ACTIV), Créteil, France; Clinical Research Center, Centre Hospitalier Intercommunal de Créteil, Créteil, France; Groupe de Pathologie Infectieuse Pédiatrique, Paris, France; Association Française de Pédiatrie Ambulatoire (AFPA), France.

出版信息

Lancet Child Adolesc Health. 2024 Nov;8(11):774-775. doi: 10.1016/S2352-4642(24)00211-6. Epub 2024 Sep 24.

DOI:10.1016/S2352-4642(24)00211-6

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Pneumococcal conjugate vaccine schedule: 3+1, 2+1, or 1+1?

Lancet Child Adolesc Health. 2024 Nov;8(11):774-775. doi: 10.1016/S2352-4642(24)00211-6. Epub 2024 Sep 24.

2

Pneumococcal conjugate vaccination schedules in infants-acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study.婴幼儿肺炎球菌结合疫苗接种程序——获得性、免疫原性，以及肺炎球菌结合疫苗和黄热病疫苗联合接种的研究。

Trials. 2022 Jan 15;23(1):39. doi: 10.1186/s13063-021-05949-4.

3

Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001-2016.肺炎球菌结合疫苗突破性感染：2001-2016 年。

Pediatrics. 2020 Mar;145(3). doi: 10.1542/peds.2019-0836. Epub 2020 Feb 13.

4

Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules.不同免疫程序儿童中由 13 价肺炎球菌结合疫苗型引起的侵袭性肺炎球菌病。

J Microbiol Immunol Infect. 2018 Apr;51(2):199-206. doi: 10.1016/j.jmii.2017.08.022. Epub 2017 Sep 27.

5

Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study.修订英格兰和威尔士 13 价肺炎球菌结合疫苗接种计划（从 2+1 改为 1+1）的预估影响：一项建模研究。

PLoS Med. 2019 Jul 3;16(7):e1002845. doi: 10.1371/journal.pmed.1002845. eCollection 2019 Jul.

6

Pneumococcal conjugate vaccination schedules in infants-acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study: statistical analysis plan.婴幼儿肺炎球菌结合疫苗接种程序——获取、免疫原性，以及肺炎球菌结合疫苗和黄热病疫苗联合使用的研究：统计分析计划。

Trials. 2024 Mar 26;25(1):216. doi: 10.1186/s13063-024-08036-6.

7

Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule.13 价肺炎球菌结合疫苗免疫应答与减少接种剂量方案。

Vaccine. 2013 Oct 1;31(42):4765-74. doi: 10.1016/j.vaccine.2013.08.009. Epub 2013 Aug 16.

8

Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial.7价肺炎球菌结合疫苗减量接种方案对儿童鼻咽部肺炎球菌携带情况的影响：一项随机对照试验

JAMA. 2009 Jul 8;302(2):159-67. doi: 10.1001/jama.2009.975.

9

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group.197位携带CRM的七价肺炎球菌结合疫苗在镰状细胞病婴儿中的安全性和免疫原性。肺炎球菌结合疫苗研究小组。

Pediatrics. 2000 Nov;106(5):965-72. doi: 10.1542/peds.106.5.965.

10

Potential impact of replacing the 13-valent pneumococcal conjugate vaccine with 15-valent or 20-valent pneumococcal conjugate vaccine in the 1 + 1 infant schedule in England: a modelling study.在英格兰，1 + 1 婴儿免疫计划中用 15 价或 20 价肺炎球菌结合疫苗替代 13 价肺炎球菌结合疫苗的潜在影响：一项建模研究。

Lancet Public Health. 2024 Sep;9(9):e654-e663. doi: 10.1016/S2468-2667(24)00161-0. Epub 2024 Aug 14.

引用本文的文献

1

Effectiveness of a Single Dose of Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Children: A Systematic Literature Review.单剂量肺炎球菌结合疫苗对儿童侵袭性肺炎球菌疾病的有效性：一项系统文献综述

Infect Dis Ther. 2025 Aug 19. doi: 10.1007/s40121-025-01211-5.